版本:
中国

BRIEF-Agenus says plans to close Basel site, combine key functions to Cambridge, UK and Lexington, MA facilities

March 30 Agenus Inc

* Agenus restructures business to sharpen focus on clinical development of cancer therapies

* Agenus - plans to close Basel site, consolidate key functions to Cambridge, UK and Lexington, MA facilities, and phase out approximately 50 positions

* Agenus Inc - Robert Stein, M.D., Ph.D., president of research and development, will retire to become a senior research and development advisor exclusive to Agenus

* Says as part of restructuring, approximately 50 positions are planned to be phased out within next six months Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐